Last reviewed · How we verify
Intra-articular platelet-rich plasma
Intra-articular platelet-rich plasma is a Small molecule drug developed by King Hamad University Hospital, Bahrain. It is currently FDA-approved. Also known as: Prp.
At a glance
| Generic name | Intra-articular platelet-rich plasma |
|---|---|
| Also known as | Prp |
| Sponsor | King Hamad University Hospital, Bahrain |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears (NA)
- Efficacy of Therapy With PRP Injections Versus HA in Patients With Advanced Grade of GONArthrosis (NA)
- Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder (NA)
- Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection. (PHASE2)
- Low-Cost Platelet-Rich Plasma for Hemarthropathy (NA)
- Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA) (NA)
- PRP in ACLR to Prevent PTOA (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-articular platelet-rich plasma CI brief — competitive landscape report
- Intra-articular platelet-rich plasma updates RSS · CI watch RSS
- King Hamad University Hospital, Bahrain portfolio CI
Frequently asked questions about Intra-articular platelet-rich plasma
What is Intra-articular platelet-rich plasma?
Intra-articular platelet-rich plasma is a Small molecule drug developed by King Hamad University Hospital, Bahrain.
Who makes Intra-articular platelet-rich plasma?
Intra-articular platelet-rich plasma is developed and marketed by King Hamad University Hospital, Bahrain (see full King Hamad University Hospital, Bahrain pipeline at /company/king-hamad-university-hospital-bahrain).
Is Intra-articular platelet-rich plasma also known as anything else?
Intra-articular platelet-rich plasma is also known as Prp.
What development phase is Intra-articular platelet-rich plasma in?
Intra-articular platelet-rich plasma is FDA-approved (marketed).
Related
- Manufacturer: King Hamad University Hospital, Bahrain — full pipeline
- Also known as: Prp
- Compare: Intra-articular platelet-rich plasma vs similar drugs
- Pricing: Intra-articular platelet-rich plasma cost, discount & access